Tsuchimoto Kim R

Monopar Therapeutics Inc. · Director

Tsuchimoto Kim R is listed in filings as Director at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Dec 8, 2025, including sale activity. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Jul 2, 2024 to Dec 8, 2025. Reported amounts are shown as $222.0K to $45. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceLast Price
Monopar Therapeutics Inc.MNPR$356k8.9k sharesSellJul 14, 2025$40.00$64.55